Aurora, Canada

Heman Lap Man Chao

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Heman Lap Man Chao: Innovator in Cancer Treatment

Introduction

Heman Lap Man Chao is a notable inventor based in Aurora, CA. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Chao's work focuses on enhancing the efficacy of immune cells in combating cancer.

Latest Patents

Chao's latest patents include groundbreaking methods and compositions aimed at restoring the function of tumor acidified T cells. One of his notable inventions involves administering urease to T cells to improve their functionality. Additionally, he has developed compositions and methods for treating cancer in humans using engineered CARs (chimeric receptor antigens). This invention specifically targets VEGFR-2 on solid tumors, utilizing CAR-T cells that recognize this receptor. His work includes therapeutic methods to treat VEGFR-2 dependent cancers by targeting tumor angiogenesis.

Career Highlights

Throughout his career, Heman Lap Man Chao has worked with various organizations, including Helix Biopharma Corporation. His innovative approaches have positioned him as a key figure in the development of cancer therapies.

Collaborations

Chao has collaborated with notable individuals in the field, including Wah Yau Wong and Baomin Tian. These partnerships have furthered his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Heman Lap Man Chao's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…